Sentiment-Signal
Score-Verlauf (90 Tage)
Stammdaten
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a test that provides longitudinal determination of cancer burden through methylation assessment. The company was incorporated in 2016 and is headquartered in Menlo Park, California.
Unternehmen & Branche
| Name | BillionToOne, Inc. |
|---|---|
| Ticker | BLLN |
| CIK | 0002070849 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Diagnostics & Research |
| SIC | 8071 · Services-Medical Laboratories |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 3,38 Mrd. USD |
| Beta | -2,36 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 305,112,000 | 7,454,000 | 0.14 | 632,654,000 | 480,105,000 |
| 2025-09-30 | 10-Q | 83,523,000 | 5,711,000 | 0.10 | 327,521,000 | -239,513,000 |
| 2024-12-31 | 10-K | 152,582,000 | -41,570,000 | -4.12 | 302,059,000 | -251,656,000 |
| 2024-09-30 | 10-Q | 38,419,000 | -14,904,000 | -1.47 | -242,854,000 | |
| 2023-12-31 | 10-K | 71,729,000 | -82,683,000 | -8.45 | -219,053,000 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2025-11-07 | Bremner Thomas S | Director | Open Market Purchase | 3,462 | 60.00 | 207,720.00 | +71,9% | |
| 2025-11-07 | Bremner Thomas S | Director | Open Market Purchase | 4,016 | 60.00 | 240,960.00 | +83,4% | |
| 2025-11-07 | Bremner Thomas S | Director | Open Market Purchase | 4,084 | 60.00 | 245,040.00 | +84,8% | |
| 2025-11-07 | Bremner Thomas S | Director | Open Market Purchase | 5,446 | 60.00 | 326,760.00 | +113,1% | |
| 2025-11-07 | Bremner Thomas S | Director | Open Market Purchase | 6,867 | 60.00 | 412,020.00 | +142,6% | |
| 2025-11-07 | Bremner Thomas S | Director | Open Market Purchase | 17,791 | 60.00 | 1,067,460.00 | +369,5% | |
| 2025-11-07 | Tsao David | Director, Officer, Chief Technology Officer | Open Market Purchase | 1,000 | 60.00 | 60,000.00 | +20,8% | |
| 2025-11-07 | Rai Akshay | Director | Open Market Purchase | 2,500 | 60.00 | 150,000.00 | +51,9% | |
| 2025-11-07 | Lynch Thomas P. | Officer, See Remarks | Open Market Purchase | 100 | 60.00 | 6,000.00 | +2,1% | |
| 2025-11-07 | ten Bosch John Roderick | Officer, See Remarks | Open Market Purchase | 800 | 60.00 | 48,000.00 | +16,6% | |
| 2025-11-07 | Johnson Nancy JoAnn | Officer, See Remarks | Open Market Purchase | 6,900 | 60.00 | 414,000.00 | +143,3% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.